GENF — Genflow Biosciences Cashflow Statement
0.000.00%
Last trade - 00:00- £7.87m
- £7.18m
Annual cashflow statement for Genflow Biosciences, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -0.142 | -0.988 | -1.34 | -1.63 |
| Depreciation | ||||
| Non-Cash Items | 0.09 | 0.069 | 0.143 | 0 |
| Other Non-Cash Items | ||||
| Changes in Working Capital | 0.027 | 0.172 | -0.177 | -0.028 |
| Change in Accounts Receivable | ||||
| Change in Payable / Accrued Expenses | ||||
| Cash from Operating Activities | -0.024 | -0.747 | -1.37 | -1.66 |
| Capital Expenditures | — | — | -0.002 | -0.002 |
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | 0 | 0.199 | — | — |
| Sale of Business | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | 0 | 0.199 | -0.002 | -0.002 |
| Financing Cash Flow Items | — | — | -0.263 | 0 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Cash from Financing Activities | 0.201 | 0.784 | 3.5 | 0 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 0.177 | 0.235 | 2.13 | -1.67 |